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Introduction
Membrane lipids play a primary role in determing
both the organization and function of membranes that
justifies the interest in analytical methods for lipid me-
asurements in a membrane. In human cells, free cho-
lesterol is normally found exclusively in membranes
where it is asymmetrically distributed between the in-
tracellular and plasma membranes. The mechanism
of cholesterol effects on membrane and cell function
presumably results in part from its ability to modulate
the biophysical properties of the membrane bilayer
(1’3). The content of cholesterol in membranes is also
important in regulation of the membrane protein tran-
sporters and cell functions (4, 5). 
The erythrocyte membrane is a model for the
plasma membranes of more complex cells. Our know-
ledge of plasma membranes of human cells have be-
en greatly advanced by study of the erythrocyte mem-
brane because it possesses several unique features:
(1) it is a simple membrane, with far fewer compo-
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Summary: Quantification of cholesterol in biological membranes is an important step toward understan-
ding of metabolism of intracellular cholesterol, composition of cell membrane and plasma lipid profile. The aim
of our study was to optimize the method for determination of cholesterol in erythrocyte membrane and then to
use this method in the determination of cholesterol concentration in erythrocyte membrane in the studied group
of blood samples. Cholesterol in erythrocyte membrane was determined in dry lipid extract of erythrocyte mem-
brane by the enzymatic manual CHOD-PAP method. Cholesterol in erythrocyte membrane and plasma lipid
parameters (total cholesterol, HDL-cholesterol, LDL-cholesterol and triglycerides) were determined in blood sam-
ples of 58 females, obtained by routine health control. Lipid parameters were determined by standard biochemi-
cal methods. We examined the relationship between cholesterol in erythrocyte membrane and other plasma lipid
parameters as well as other atherogenic risk factors (BMI, blood pressure). Optimisation of the method for deter-
mination of cholesterol in erythrocyte membrane was based on the observation that primary cholesterol standards
prepared by dissolving crystal cholesterol cannot be used due to the interference of the dissolved dry extract in
organic solvents with the enzymatic reagent. Commercial standard solutions of cholesterol were used for calibra-
tion because they contain detergents for solubilisation of the dry extract in enzymatic reagent. The obtained mean
value for cholesterol in erythrocyte membrane, as mmol/L erythrocyte is 4.44 ± 1.019; median 4.65; 5-th per-
centile is 2.70, and 95-th percentile is 6.26. In the examined female group we tested cholesterol concentration in
erythrocyte membrane according to age. Two groups were formed (females below and above 50 years); using
nonparametric t-test no statistically significant difference was found between these two age groups (p>0.05),
while plasma lipid parameters of total cholesterol, triglycerides and LDL-cholesterol were different in the exami-
ned groups (p<0.05). By Spearmen nonparametric correlation method we found no statistically significant corre-
lation between cholesterol in erythrocyte membrane and other atherogenic risk factors. 
Key words: membrane cholesterol, erythrocyte membrane, dyslipidaemia, atherogenic risk
Abbreviations: TC’total cholesterol; TG’ triglycerides; HDL-C’ HDL-cholesterol and LDL-C-LDL-holes-
terol.
nents than plasma membrane of, for example, a hepa-
tocyte; (2) the erythrocyte membrane is the only mem-
branous component of the human erythrocyte; in con-
trast, the plasma membrane of a hepatocyte compris-
es only about 2 % of the total membrane of the cell,
and (3) erythrocyte membrane may be prepared sim-
ply and in large amounts. 
In view of the role of excess serum cholesterol as
a risk factor of atherosclerosis and its potential link to
altered arterial cell and membrane function, the pre-
sent study was designed to determine the possible
relationship between cholesterol in membrane and
lipid profile in plasma. In this purpose we determined
the concentration of cholesterol in erythrocyte mem-
brane and TC, TG, HDL-C, LDL-C in serum. For rou-
tine determination of cholesterol in erythrocyte mem-
brane a highly sensitive and rapid method is needed
with reliable imprecision and inaccuracy of the proce-
dure so we optimised the method for determination of
cholesterol in isolated erythrocyte membrane. We
analysed also the distribution of cholesterol in erythro-
cyte membrane within different age groups and the
influence of non-lipid atherogenic factors such as BMI,
systolic and diastolic pressure.  
Material and Methods
Blood samples were obtained from 58 apparen-
tly healthy unrelated females, aged from 22 to 64
years. Informed consent was obtained from all sub-
jects. Serum lipid profile analyses were carried out on
blood samples collected after a 12h fasting period.
Serum was separated by centrifugation at 3000 rpm
and lipid parameters were immediately determined.
Blood samples were collected in K3EDTA tubes for
determination of cholesterol in erythrocyte membra-
ne. Haemolysates were prepared from washed ery-
throcytes and stored at ’70 °C. The samples were
thawed immediately before analysis. TC and TG were
measured by standard enzymatic methods, using
commercial reagent kits from Boehringer-Mannheim
on multichannel analyser Hitachi 704. HDL-C was
assayed by the same enzymatic method used for the
TC measurement, after precipitation with phospho-
tungstic acid in presence of magnesium ions. The
concentration of LDL-C was calculated with the Frie-
dewald’s formula (6).
Enzymatic assay for cholesterol 
in erythrocyte membranes
Cholesterol in erythrocyte membrane was manu-
ally determined in dry lipid extracts of the membrane
by the enzymatic CHOD-PAP method using commer-
cial kit (Randox Laboratories, Ltd. Grumlin, United
Kingdom). Erythrocytes were first separated and was-
hed from plasma. Lipids were extracted using a modi-
fication of a procedure previously described (7, 8). 
Determination of cholesterol in erythrocyte
membrane was performed in several steps. Erythro-
cytes were first three times washed with physiological
solution and packed erythrocytes were then haemo-
lyzed by adding distilled water in proportion (1:2); 0.5
mL of this haemolysate was transferred into a stop-
pered glass tube. With an automatic pipette 5 mL of
isopropanol was added, drop-by-drop to a glass tube
continuously mixing on vortex. The mixture was left
for one hour at room temperature. Then, 3.2 mL of
chloroform were added as described for isopropanol.
After overnight storage in dark, at room temperature
the tubes were virtuously mixed. The content of the
tube was transferred into a glass tube graduated up
to 15 mL and centrifuged for 10 minutes at 3000
rpm; 600 mL of the supernatant was evaporated un-
der vacuum and warming at 60 °C. Each sample was
evaporated in triplicate.
Dry residue was completely dissolved in 2 mL of
CHOD-PAP reagent (Randox) with adding 0.5 % of
Triton X-100. Detergent Triton X-100 must be added
to the reagent solution to ensure solubilization of the
lipid extracts during assay procedure. The detergent
did not interfere with the assay. Incubation was carried
out at room temperature for 30 minutes. Tubes were
mixed several times on vortex until the dry residues
were completely dissolved. Absorbances of the sam-
ples were measured at 500 nm on DU-8 spectropho-
tometer (Beckman). Blank and cholesterol standard
were treated in same way as the sample after the prepa-
ration of haemolysate.  Concentration of cholesterol in
erythrocyte membrane was calculated using a com-
mercial cholesterol standard (5.17 mmol/L). Values of
cholesterol in erythrocyte membrane were expressed
as mmol of cholesterol per L of erythrocytes.
Statistical Methods
All values are expressed as mean ± SD. The
examined group of females was divided in two age
groups. Comparison of cholesterol in erythrocyte
membrane, serum lipid values, BMI, diastolic and sys-
tolic pressure among different age groups was per-
formed by Mann-Whitney's U-test. Significance was
accepted at p<0.05. Cholesterol in erythrocyte mem-
brane was also correlated with the serum lipids levels
by linear regression analysis. Using statistical pro-
grams STATGRAPHIC R, VER. 4.2 and STATISTICA
FOR VINDOWS, VER. 5.0 we performed statistical
analyses.
Results
Optimisation of the assay for cholesterol 
in erythrocyte membrane 
Quantitative determination of free cholesterol
extracted from erythrocyte membrane is based on the
same enzymatic method for determination of serum
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total cholesterol and lipoprotein fractions of choles-
terol. When used for cholesterol in membrane there
were some problems. Two aspects are of importance
for the modified procedure: optimisations in the pre-
analytic treatment of the samples and standardisation
of the method with an adequate water-soluble stan-
dard. 
Lipid extraction from erythrocyte membrane was
done by a combination of chloroform and isopro-
panol. Combination of chloroform as nonpolar and
isopropanol as polar solvent, totally destroys hydrogen
and electrostatic bonds in the lipid membrane bilayer
and denatures membrane proteins.
Standardisation of the method was done with
two groups of standards: primary cholesterol stan-
dards prepared in our laboratory and commercially
available cholesterol standards. Primary cholesterol
standards were prepared by dissolving the cholesterol,
a water insoluble substance, in three organic solvents:
absolute ethanol, chloroform and isopropanol. Con-
centration of the prepared standard was 5.17 mmol/L.
Cholesterol was totally dissolved in chloroform and
isopropanol, but in absolute ethanol it must be war-
med and continuously mixed for 2’3 hours. Com-
mercial Preciset cholesterol standards (3.88 and 5.17
mmol/L), Boehringer Mannheim were used. 
Experimental results suggest that different sol-
vents for preparation of primary standards interfere
with the enzymatic reaction. The influence of iso-
propanol is most evident at the final enzymatic reac-
tion so the absorbance of the product is very high.
Next problem was the poor solubility of dry extracts
after evaporation of primary cholesterol standards in
CHOD-PAP reagent even after addition of the deter-
gent (Triton X-100). Solubility was not better even by
warming at 60 °C and continuous mixing. Dry extracts
prepared from commercial cholesterol standards were
completely dissolved after rigorous mixing 2 to 3 mi-
nutes at room temperature. 






















































































































































Table I   Lipid and non-lipid parameters in the examined groups. Group I ’ all women; 
Group II women younger than fifty years and group III women elder than fifty years.
* Statistically significant difference (p<0.05) between two age groups.
Imprecision of the method was evaluated in dif-
ferent samples of erythrocyte membranes. Small sam-
ple volume of erythrocytes is the limited factor for this
assay because it is not possible to prepare numerous
extracts from the same sample. From every sample we
prepared one extract in which the concentration of
cholesterol was determined in triplicate. Assuming the
small sample volume standard deviation was deter-
mined by a pair difference method. The lowest value
was subtracted from the highest value for the same
extract. Calculating from 20 pairs of samples we ob-
tained the following values: 0.253 mmol/L Er for stan-
dard deviation and 5.89 % for coefficient of variation. 
Cholesterol in erythrocyte membrane
Concentrations of cholesterol in erythrocyte
membrane, TC, TG, HDL-C, LDL-C in serum, and va-
lues for BMI, systolic and diastolic pressure in three
age groups of women are summarized in Table I. To
better illustrate the possible influence of old age and
the effects of the decrease in female sex hormones
after menopause, we divided the subjects in two
groups according to age groups (females below and
above 50 years). The cut-off of 50 years was chosen
because this value is usually considered to be the
mean age of menopause, at least in the European
countries (9). Data for all three groups (Group I all sub-
jects N=58; Group II age < 50 years N=49; Group III
age ≥ 50 years N = 9) are presented as mean value
± SD, median and 5-th and 95-th percentile values.
Statistical differences between these two age groups
for all examined parameters: cholesterol in erythrocyte
membrane, TC, TG, HDL-C and LDL-C were tested by
Mann-Whitney's U-test and the statistical probability is
given in the Table I.   
Mean value for cholesterol in erythrocyte mem-
brane in the examined group of women is 4.44 ±
1.019 mmol/L Er. Values for cholesterol in erythrocyte
membrane were lower in women aged 50 years and
more, but this difference is not statistically significant
(p>0.05). Calculated percentile values have similar
variations with age. The obtained value for the 95-th
percentile for group II is also lower compared with the
older group (5.88 vs. 6.26 mmol/L Er). 
TC and LDL-C values were evidently influenced
by age. Obtained values for these parameters are sta-
tistically signicantly higher in women aged 50 years
and more (p<0.05). TG were also markedly higher in
the older group (p<0.05). HDL-C as an antiathero-
genic lipid parameter was lower in women aged 50
years and more, but not significantly compared with
the other age group (1.16 ± 0.321 vs. 1.31 ± 0.326
mmol/L, p>0.05).        
It is well known that hyperlipoproteinaemia, obe-
sity and hypertension constitute the main risk factors
in atherogenesis and coronary heart disease. Assu-
ming the aetiology of atherosclerosis we examined the
correlation of cholesterol in erythrocyte membrane
with lipid and non-lipid risk factors. We assessed the
correlation between the concentration of the meas-
ured cholesterol in erythrocyte membrane with the
concentrations of lipid parameters (TC, TG, HDL-C
and LDL-C) and the level of BMI, systolic and diastolic
pressure. In Table II results of the Spearmann-Pear-
son correlation method for all lipid and non-lipid pa-
rameters are presented. Negative correlations were
found between cholesterol in erythrocyte membrane
and other examined parameters, but these low corre-
lation coefficients were not statistically significant. In
our study BMI varied from 17.84 to 31.89 kg/m2 and
is probably of no importance for our results since no
association between BMI and cholesterol in erythro-
cyte membrane has been reported.
Discussion
Epidemiological studies have indicated that ele-
vations in plasma cholesterol constitute a principal
and independent risk factor in the aetiology of athero-
sclerotic lesions and coronary heart disease. However,
the cellular role that elevated cholesterol plays in this
disease, and how it leads to lesion formation, is still
intensely studied. The present study was designed to
explore potential alterations of cholesterol in erythro-
cyte membrane associated with serum lipid profile as
a predictor of atherosclerosis. As the determination of
cholesterol in erythrocyte membrane is still an analyti-
cal problem, we used and optimized an enzymatic
method for determination of cholesterol in serum.
Several pathologies affect cholesterol in erythrocyte
membrane, but its measurement has yet no relevant
clinical application  (10’12). The lack of simple and
reliable analytical procedures does not allow a defini-
tive agreement on the normal range of cholesterol
concentrations in erythrocyte membranes.     
Cholesterol in erythrocyte membrane is extracted
with organic solutions and after evaporation of the sol-

























Table II   Correlation coefficients between cholesterol in erythrocyte membrane and other lipid or non-lipid parameters
vent the dry extract is dissolved and cholesterol esti-
mated. Cholesterol in the dry extract is also insoluble
in water so addition of the detergent Triton X-100 to
the extract is necessary (7). Dry extract is directly dis-
solved in the reagent mixture of CHOD-PAP reagent
because all commercial reagents already contain
detergents. We studied the effect of added Triton X-
100 to the reaction mixture for better dissolving of the
dry extract. Our conclusion was that CHOD-PAP rea-
gent from Randox Company already contains enough
detergent.  
The method must be standardized in every step:
blood drawing, washing of erythrocyte and lipid extrac-
tion. The choice of anticoagulant is also important.
We used K3EDTA, but some authors used Li-heparin
for collection of samples and the obtained results were
4% higher (8). Suitable erythrocyte packing is of pri-
mary importance for the reproducibility of the method.
We emphasize that the indications given for the cen-
trifugations have to be exactly followed. Under these
conditions of centrifugation haematocrit always ran-
ged 48 ’50 %. The results are expressed as mmol of
cholesterol per 1 L of packed erythrocytes but different
authors express the results in different units: mg/100
mL RBC, mg/mL RBC, nmol/109 cells, mmol/L RBC
(8).
Extraction was optimised by choosing an adequ-
ate reaction mixture. Experiment results of our study
confirm that chloroform-isopropanol mixture is pre-
ferred to chloroform-methanol and hexan-isopropanol
mixture (8, 13). This combination is optimal for com-
plete extraction of cholesterol from the erythrocyte
membrane, higher lipid extraction rates and no con-
tamination with pigments. The extraction must be do-
ne by continuous adding of extraction mixture, drop-
by-drop and mixing. Following strictly instructions for
extraction the membrane structures are completely
disintegrated, cholesterol totally extracted so there is
no need for repeated extraction.  
Better results are obtained with commercially
available standards of cholesterol than with primary
standards prepared in the laboratory. Primary stan-
dards of cholesterol prepared in different organic sol-
vents such as ethanol, chloroform and isopropanol
interfere with the solubility of the dry extract and the
final enzymatic reaction. Cholesterol is an insoluble
substance in water, poorly soluble in ethanol, much
better dissolved in warmed ethanol and completely
soluble in organic solvents (chloroform, isopropanol,
ether). Evaporated extracts of primary cholesterol
standards prepared by dissolving cholesterol in organ-
ic solvent were poorly dissolved in the enzymatic
reagent even after addition of the detergent, Triton X-
100. This was not a problem with samples because
erythrocyte membrane extracts have nature cell solu-
bilisators. All these problems were negotiated using
commercial available primary cholesterol standards
that already contain detergents and cholesterol solu-
bilisators. Dry extracts of standards are completely dis-
solved in enzymatic CHOD-PAP reagent. Some aut-
hors recommend the Beckman Instrument instruction
for preparation of cholesterol standard (14). Chole-
sterol is dissolved in Triton-X-100 detergent by heating
and occasional stirring. The cholesterol solution was
than cooled; distilled water and Tris puffer (pH=7.4)
were added to the proposed volume. Optimised met-
hod is accurate in determing plasma membrane cho-
lesterol content and the precision of this method is
also high. Precision is evident from relatively small
standard deviations of replicates SD = 0.253 mmol/L
Er and CV = 5.89 %.
The major advantages of the procedure for de-
termination of the total cholesterol content in mem-
brane lipid extracts described in the present study are
the sensitivity, easy handling and the rapidity by which
the assays can be performed. Furthermore, since
dried lipid extracts are used, the assay procedure is
insensitive to influences of different solvents for lipid
extraction. 
Optimised method was used for determination
of cholesterol in erythrocyte membrane and the
obtained mean value in our group of subjects was
4.44 mmol/L Er, median value 4.65 mmol/L Er, 5-th
percentile 2.70 mmol/L Er and the 95-th percentile
was 6.26 mmol/L Er (Table I). Our results agree with
the studies of Maccia et al. (8) who examined choles-
terol concentrations in erythrocyte membranes within
Italic healthy population (mean value: 3.41 mmol/L
Er, median: 3.41 mmol/L Er, 5-th percentile: 2.70
mmol/L Er and 95-th percentile 4.13 mmol/L Er). The
obtained higher mean value and 95-th percentile of
cholesterol in our studied group can be explained in
terms of the effect of different diets between these two
populations. Effect of dietary habits on cholesterol in
membrane is based on the fact that most of cellular
cholesterol is distributed in the plasma membrane.
Enrichment of the plasma membrane with cholesterol
in dietary atherosclerosis has been demonstrated
(15). 
Atherosclerotic risk is commonly based on me-
asurement of lipid parameters in sera, such as TC, TG,
LDL-C and HDL-C. Influences of lipid parameters and
other risk factors (age, BMI and blood pressure) on
cholesterol in erythrocyte membranes as a potential
atherogenic marker, were analysed. As serum lipid pro-
file changes with age, all lipid and non-lipid parameters
were compared between two age groups (Table I).
Older women had significantly higher values (p<0.05)
of TC, TG and LDL-C, which is in agreement with other
epidemiological studies. Cholesterol in erythrocyte
membrane and HDL-C were not affected by age. 
To explore whether cholesterol levels in erythro-
cyte membrane were higher in presence of higher se-
rum TC and LDL-C concentrations, we correlated the
cholesterol concentrations in erythrocyte membrane
with the corresponding lipid profile, hypertension and
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BMI, risk factors for initiation and progression of
atherosclerosis (Table II). There was no correlation
among the examined parameters, although there is lit-
erature evidence for direct correlation of cholesterol
with age, gender, BMI, systolic and diastolic pressure
as well as concentrations of TG, HDL-C and serum
phospholipids (16). Highest influence was observed
for age, gender and concentrations of TG in serum,
while arteric hypertension lowers the cholesterol in ery-
throcyte membrane (17). 
Although we obtained no correlation between
cholesterol in membrane erythrocyte and TC and
LDL-C, there is evidence that hypercholesterolemia
influences deposition of cholesterol in the extracellular
part of the erythrocyte membrane and sometimes
even changes the shape of normal erythrocytes in
acantocytes. Accumulation of cholesterol in the mem-
brane causes the rigidity of the membrane in acanto-
cytes. Literature data suggest that atherosclerosis
alters the composition, structure and function of plas-
ma membranes (18). Patients with atherosclerotic
lesions have modified lipid structure in membranes,
altered ratio of cholesterol/phospholipid and modified
fluidity of the membrane (19, 20). Diagnosis of ather-
osclerosis is based on early structural modifications of
the cells, so determination of cholesterol in erythrocyte
membrane or the cholesterol/phospholipid ratio can
be an important diagnostic parameter of the physico-
chemical alteration within the cell in the reversely
phase. 
We have described a sensitive, simple and accu-
rate method for determining the cholesterol content in
biological membrane. Our data contribute to the stan-
dardisation of the method in every step, determining
the reference values and establishing the relation bet-
ween cholesterol in membrane with some pathological
states, especially the influence of cholesterol in mem-
brane on determination of atherogenic risk and further
development of atherosclerosis.  
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Kratak sadr`aj: Odre|ivanje membranskog holesterola je va`an stepen u utvr|ivanju povezanosti intracelu-
larnog metabolizma holesterola, sastava }elijske membrane i plazmatskog lipidnog profila. Prvi cilj ovog rada je
bio optimizacija metode za odre|ivanje membranskog holesterola {to je podrazumevalo izbor standarda i primenu
enzimskog testa. Holesterol u membrani eritrocita odre|ivan je ru~no u suvom lipidnom ekstraktu membrane,
enzimskom CHOD-PAP metodom firme Randox. Optimizirana metoda je primenjena za odre|ivanje koncen-
tracija holesterola u membrani eritrocita kod 58 `ena kojima je krv uzeta na rutinskom sistematskom pregledu. U
ispitivanim uzorcima odre|en je i serumski lipidni profil standardnim biohemijskim metodama. Ispitivane `ene su
podeljene u dve starosne grupe: na mla|e od 50 godina i na starije od 50 godina. Ispitan je i stepen povezanos-
ti izme|u membranskog holesterola sa jedne strane i plazmatskih lipida i drugih faktora rizika za aterosklerozu
(starosti, BMI, sistolni i dijastolni pritisak) sa druge strane. Optimizacijom metode za odre|ivanje membranskog
holesterola do{lo se do zaklju~ka da se ne mogu koristiti primarni standardni rastvori holesterola dobijeni rast-
varanjem kristalnog holesterola u organskom rastvara~u zbog slabe rastvorljivosti suvog ekstrakta u enzimskom
reagensu i uticaja pojedinih rastvara~a na bojenu reakciju. Za kalibraciju treba koristiti komercijalne standardne
rastvore holesterola jer sadr`e deterd`ente koji omogu}avaju rastvorljivost suvog ekstrakta. U ispitivanoj populaciji
dobijena srednja vrednosti za holesterol u membrani eritrocita (izra`ene kao mmol/L eritrocita) iznosi 4,44 ±
1,019, mediana 4,65, 5-ti percentil iznosi 2,70, a 95-ti percentil je 6,26. Pore|enjem ispitivanih parametara izme-
|u dve starosne grupe za holesterol u eritrocitnoj membrani nije bilo zna~ajne razlike (p>0,05) dok je za ukupan
holesterol, LDL-holesterol i  trigliceride ova razlika bila statisti~ki zna~ajna (p<0,05). Primenom Spearman-ove
neparametarske korelacije nije na|ena statisti~ki zna~ajna korelacija izme|u membranskog holesterola i drugih
faktora rizika za aterosklerozu.
Klju~ne re~i: holesterol u membrani, eritrocitna membrana, dislipidemija, aterogeni rizik. 
Skra}enice: uH-ukupan holesterol; TG-trigliceridi; HDL-H HDL-holesterol; LDL-H - LDL-holesterol.
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